GAD2 is localized to the nerve terminal and is reversibly bound to the membrane of synaptic vesicles, which has been linked with lower birth weights and additional risk for metabolic diseases [35], whereas GAD1 is a cytosolic enzyme distributed throughout the organs and central nervous system [36]. The gene discussed is GAD1; the disease is metabolic disease.